Albumin Substitution in Decompensated Liver Cirrhosis: Don’t Forget Zinc
Decompensated liver cirrhosis has a dismal prognosis, with patients surviving on average for 2–4 years after the first diagnosis of ascites. Albumin is an important tool in the therapy of cirrhotic ascites. By virtue of its oncotic properties, it reduces the risk of cardiovascular dysfunction after...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
MDPI AG
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/a20f9cfe3ead4174bc1a66af0e573311 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|